BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Antengene Announces Clinical Trial Collaboration with BeiGene

Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor Antengene Corporation Limited ("...

June 27, 2022 | News

Mojia Biotech Completes Series B Financing to Advance Manufacturing of Bio-based Materials

Mojia Biotech, a Shanghai-based leading bio-manufacturing company dedicated to sustainable development and carbon neutrality, announced the completion...

June 23, 2022 | News

META raised 15M USD to accelerate its pipeline development

META Pharmaceuticals, China's first immunometabolism-based small-molecule drug discovery company, announced two consecutive Seed and Pre-A fundin...

June 14, 2022 | News

Harbour BioMed Announces IND Approval for B7H4x4-1BB Bispecific Antibody

This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of HBM7008 in patients with soli...

June 09, 2022 | News

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative im...

June 07, 2022 | News

CPHI China opens for international partnering after China rises in CPHI Index

CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country repo...

June 06, 2022 | News

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-...

June 06, 2022 | News

Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US

The Pre-ASCO Live Zoom series was watched by more than 20,000 people globally. The Novotech-sponsored panels, China CST 9:00-10:30 AM (May 14); US EST 9:00...

June 03, 2022 | News

The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures

Zelixir Biotech announces it has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes amid the re...

May 31, 2022 | News

I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab

Encouraging efficacy signals were observed in a non-small cell lung cancer (NSCLC) patient cohort - Results indicate CD73 expression corr...

May 27, 2022 | News

SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit

SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (ConformitéEuropéenne) Mark approval...

May 26, 2022 | News

New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer

New Horizon Health and Prenetics will jointly promote ColoClear in Hong Kong, Macau and Taiwan, with additional options to expand the p...

May 24, 2022 | News

INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China

INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment...

May 17, 2022 | News

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

The planned Phase 1 study is a double-blind, randomized, placebo-controlled, single and multiple dose escalation study in healthy subjects. The study aims ...

May 16, 2022 | News

Stay Connected